Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Imaging in Primary Sjogren’s Syndrome
Published in: Journal of Clinical Medicine
Access to document
10.3390/jcm9082492
document
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized by dysfunction and lymphocytic infiltration of the salivary and lacrimal glands. Besides the characteristic sicca complaints, pSS patients can present a spectrum of signs and symptoms, which challenges the diagnostic process. Various imaging techniques can be used to assist in the diagnostic work-up and follow-up of pSS patients. Developments in imaging techniques provide new opportunities and perspectives. In this descriptive review, we discuss imaging techniques that are used in pSS with a focus on the salivary glands. The...
Visualizing bicalutamide effect on androgen receptor availability in patients with metastatic breast cancer
Published in: Cancer Research
Access to document
10.1158/1538-7445.AM2020-803
Jorianne Boers, Clasina M. Venema, Erik F. J. de Vries, Geke A. P. Hospers, Hendrikus H. Boersma, Bart Rikhof, Christine Dorbritz, Andor W. J. M. Glaudemans, Carolina P. Schroder
Tc-99m-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?
Published in: Journal of Nuclear Cardiology
Access to document
10.1007/s12350-019-01917-3
document
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis
Published in: SEMINARS IN ARTHRITIS AND RHEUMATISM
Access to document
10.1016/j.semarthrit.2020.04.002
document
BACKGROUND AND AIM: Assessing cranial artery inflammation plays an important role in the diagnosis of cranial giant cell arteritis (C-GCA). However, current diagnostic tests are limited. The use of fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT imaging is an established tool for assessing large vessel inflammation but is currently not used for assessment of the cranial arteries. This study aimed to evaluate the accuracy of FDG-PET/CT in the diagnosis of biopsy proven C-GCA and its relation to clinical presentation. METHODS: This retrospective case control study included temporal artery biopsy...
Application of PET Tracers in Molecular Imaging for Breast Cancer
Published in: Current oncology reports
Access to document
10.1007/s11912-020-00940-9
document
Purpose of Review: Molecular imaging with positron emission tomography (PET) is a powerful tool to visualize breast cancer characteristics. Nonetheless, implementation of PET imaging into cancer care is challenging, and essential steps have been outlined in the international “imaging biomarker roadmap.” In this review, we identify hurdles and provide recommendations for implementation of PET biomarkers in breast cancer care, focusing on the PET tracers 2-[18F]-fluoro-2-deoxyglucose ([18F]-FDG), sodium [18F]-fluoride ([18F]-NaF), 16α-[18F]-fluoroestradiol ([18F]-FES), and [89Zr]-trastuzumab. Recent Findings: Technical validity of [18F]-FDG, [18F]-NaF, and [18F]-FES is established and supported by international...
Jorianne Boers, Erik F. J. de Vries, Andor W. J. M. Glaudemans, Geke A. P. Hospers, Carolina P. Schröder